• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The role of HIV in serious diseases other than AIDS.

作者信息

Phillips Andrew N, Neaton James, Lundgren Jens D

出版信息

AIDS. 2008 Nov 30;22(18):2409-18. doi: 10.1097/QAD.0b013e3283174636.

DOI:10.1097/QAD.0b013e3283174636
PMID:19005264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2679976/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f93a/2679976/e89c308935a4/nihms90591f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f93a/2679976/434d73078513/nihms90591f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f93a/2679976/f2d4c8d0d8ed/nihms90591f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f93a/2679976/4f3548bcabf6/nihms90591f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f93a/2679976/e89c308935a4/nihms90591f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f93a/2679976/434d73078513/nihms90591f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f93a/2679976/f2d4c8d0d8ed/nihms90591f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f93a/2679976/4f3548bcabf6/nihms90591f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f93a/2679976/e89c308935a4/nihms90591f4.jpg

相似文献

1
The role of HIV in serious diseases other than AIDS.人类免疫缺陷病毒在除艾滋病之外的严重疾病中的作用。
AIDS. 2008 Nov 30;22(18):2409-18. doi: 10.1097/QAD.0b013e3283174636.
2
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.HIV感染初始治疗后的CD4+计数与非艾滋病疾病风险
AIDS. 2008 Apr 23;22(7):841-8. doi: 10.1097/QAD.0b013e3282f7cb76.
3
Risk of non-AIDS-defining events among HIV-infected patients not yet on antiretroviral therapy.尚未接受抗逆转录病毒治疗的HIV感染患者发生非艾滋病定义事件的风险。
HIV Med. 2015 May;16(5):265-72. doi: 10.1111/hiv.12202. Epub 2015 Jan 21.
4
Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.接受高效抗逆转录病毒治疗的HIV-1感染受试者的长期免疫反应。
AIDS. 2000 May 26;14(8):959-69. doi: 10.1097/00002030-200005260-00007.
5
Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.联合化疗与高效抗逆转录病毒疗法对HIV-1相关淋巴瘤免疫参数的影响。
AIDS. 2002 Mar 8;16(4):531-6. doi: 10.1097/00002030-200203080-00003.
6
HIV infection, inflammation, immunosenescence, and aging.HIV 感染、炎症、免疫衰老和衰老。
Annu Rev Med. 2011;62:141-55. doi: 10.1146/annurev-med-042909-093756.
7
How does HIV impact on non-AIDS events in the era of HAART?在高效抗逆转录病毒治疗（HAART）时代，艾滋病病毒（HIV）如何影响非艾滋病相关事件？
Int J STD AIDS. 2009 Jan;20(1):1-3. doi: 10.1258/ijsa.2008.008302.
8
Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients.免疫缺陷与经治疗的 HIV 感染患者队列中严重临床终点的风险。
AIDS. 2010 Jul 31;24(12):1877-86. doi: 10.1097/QAD.0b013e32833b1b26.
9
Immune response during HIV and tuberculosis co-infection.HIV与结核病合并感染期间的免疫反应。
Mem Inst Oswaldo Cruz. 1998 May-Jun;93(3):399-402. doi: 10.1590/s0074-02761998000300023.
10
T cells versus HIV-1: fighting exhaustion as well as escape.T细胞与HIV-1：对抗耗竭与逃逸
Nat Immunol. 2003 Jan;4(1):12-3. doi: 10.1038/ni0103-12.

引用本文的文献

1
Two-threshold defined immune non-responders are associated with long-term morbidity in people with HIV: a prospective cohort study.双阈值定义的免疫无反应者与HIV感染者的长期发病率相关：一项前瞻性队列研究。
Emerg Microbes Infect. 2025 Dec;14(1):2539198. doi: 10.1080/22221751.2025.2539198. Epub 2025 Aug 8.
2
Prevalence of thyroid dysfunction in highly active antiretroviral therapy -Exposed people living with human immunodeficiency virus.高效抗逆转录病毒治疗暴露的人类免疫缺陷病毒感染者甲状腺功能障碍的患病率
Thyroid Res. 2025 Jun 10;18(1):24. doi: 10.1186/s13044-025-00240-z.
3
Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in Italy.

本文引用的文献

1
Earlier initiation of antiretroviral therapy in treatment-naïve patients: implications of results of treatment interruption trials. 早期开始抗逆转录病毒治疗治疗初治患者：治疗中断试验结果的意义。
Curr Opin HIV AIDS. 2008 Mar;3(2):112-7. doi: 10.1097/COH.0b013e3282f3808b.
2
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.曾接受间歇性治疗的HIV患者重新开始持续抗逆转录病毒治疗后发生机会性疾病和死亡的风险：一项随机试验
Ann Intern Med. 2008 Sep 2;149(5):289-99. doi: 10.7326/0003-4819-149-5-200809020-00003.
3
在HIV-RNA检测不到的艾滋病毒感染者中选定的合并症与抗逆转录病毒治疗转换的概率：意大利的一项回顾性分析
J Antimicrob Chemother. 2025 Jul 1;80(7):1849-1859. doi: 10.1093/jac/dkaf137.
4
HIV-SEQ REVEALS GLOBAL HOST GENE EXPRESSION DIFFERENCES BETWEEN HIV-TRANSCRIBING CELLS FROM VIREMIC AND SUPPRESSED PEOPLE WITH HIV.HIV测序揭示了病毒血症期和病毒抑制期HIV感染者中HIV转录细胞之间的全球宿主基因表达差异。
bioRxiv. 2024 Dec 20:2024.12.17.629023. doi: 10.1101/2024.12.17.629023.
5
Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2.慢性 HIV 感染对 SARS-CoV-2 急性免疫反应的影响。
J Acquir Immune Defic Syndr. 2024 May 1;96(1):92-100. doi: 10.1097/QAI.0000000000003399.
6
Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons With HIV.探讨 HIV 感染者中蛋白质生物标志物对心血管疾病的因果效应。
J Infect Dis. 2023 Apr 18;227(8):951-960. doi: 10.1093/infdis/jiac496.
7
New Assay Reveals Vast Excess of Defective over Intact HIV-1 Transcripts in Antiretroviral Therapy-Suppressed Individuals.新测定法显示，在接受抗逆转录病毒治疗的个体中，缺陷型 HIV-1 转录本远远超过完整型。
J Virol. 2022 Dec 21;96(24):e0160522. doi: 10.1128/jvi.01605-22. Epub 2022 Nov 30.
8
Human immunodeficiency virus infection and risks of morbidity and death in adults with incident heart failure.成人新发心力衰竭患者的人类免疫缺陷病毒感染及发病和死亡风险
Eur Heart J Open. 2021 Dec 1;1(3):oeab040. doi: 10.1093/ehjopen/oeab040. eCollection 2021 Nov.
9
Healthcare resource utilization and costs associated with renal, bone and cardiovascular comorbidities among persons living with HIV compared to the general population in Quebec, Canada.与加拿大魁北克一般人群相比，艾滋病毒感染者的肾脏、骨骼和心血管合并症相关的医疗资源利用和费用。
PLoS One. 2022 Jul 11;17(7):e0262645. doi: 10.1371/journal.pone.0262645. eCollection 2022.
10
Immune correlates of cardiovascular co-morbidity in HIV infected participants from South India.印度南部感染 HIV 参与者的心血管合并症的免疫相关性。
BMC Immunol. 2022 May 17;23(1):24. doi: 10.1186/s12865-022-00498-0.
Determination of the underlying cause of death in three multicenter international HIV clinical trials.
三项多中心国际艾滋病临床试验中潜在死因的判定
HIV Clin Trials. 2008 May-Jun;9(3):177-85. doi: 10.1310/hct0903-177.
4
Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.抗逆转录病毒治疗中断与HIV-1感染者的心血管疾病风险：来自SMART试验的探索性分析
Antivir Ther. 2008;13(2):177-87. doi: 10.1177/135965350801300215.
5
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.1992年至2003年期间，美国艾滋病毒感染者中各类癌症的发病率与普通人群的比较。
Ann Intern Med. 2008 May 20;148(10):728-36. doi: 10.7326/0003-4819-148-10-200805200-00005.
6
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.在SMART研究中，未接受过抗逆转录病毒治疗（ART）的参与者以及基线时未接受ART治疗的参与者的主要临床结局。
J Infect Dis. 2008 Apr 15;197(8):1133-44. doi: 10.1086/586713.
7
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.HIV感染初始治疗后的CD4+计数与非艾滋病疾病风险
AIDS. 2008 Apr 23;22(7):841-8. doi: 10.1097/QAD.0b013e3282f7cb76.
8
Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.联合抗逆转录病毒疗法出现之前和之后首次艾滋病界定疾病的病因及后续生存情况。
HIV Med. 2008 Apr;9(4):246-56. doi: 10.1111/j.1468-1293.2008.00554.x.
9
Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.与仅感染丙型肝炎病毒的吸毒者相比，丙型肝炎病毒/艾滋病病毒合并感染的吸毒者中与肝炎相关的死亡风险增加：一项20年前瞻性研究。
J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):221-5. doi: 10.1097/QAI.0b013e31815d2f59.
10
Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection.丙型肝炎病毒与人类免疫缺陷病毒合并感染时肝脏炎性细胞因子mRNA的表达
J Viral Hepat. 2008 May;15(5):331-8. doi: 10.1111/j.1365-2893.2007.00949.x. Epub 2007 Dec 20.